TrialPanorama/TrialPanorama-database huggingface dataset:
Study 32023374 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 32024468 — Predictive Biomarker (PRD): SCN11A mRNA
Genes: SCN11A; SCN12A; SNS2
Study 32024468 — Predictive Biomarker (PRD): SCN9A mRNA
Genes: SCN9A; NENA
Study 32024675 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study 32026243 — Surrogate Endpoint (SUR): Forced vital capacity
Study 32026347 — Surrogate Endpoint (SUR): Forced vital capacity
Study 32026407 — Predictive Biomarker (PRD): CXCL14 mRNA
Genes: CXCL14; MIP2G; NJAC; SCYB14; PSEC0212; UNQ240/PRO273
Study 32026407 — Surrogate Endpoint (SUR): Forced vital capacity
Study 32027796 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 32027846 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 32027846 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 32027845 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 32027845 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 32027858 — Predictive Biomarker (PRD): CAP1 mRNA
Genes: CAP1; CAP
Study 32028991 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study 32028991 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 32028998 — Predictive Biomarker (PRD): ANG mRNA
Genes: ANG; RNASE5
Study 32028998 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 32032671 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study 32034630 — Predictive Biomarker (PRD): WEE1 mRNA
Genes: WEE1
Study 32034630 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 32035524 — Predictive Biomarker (PRD): GLS mRNA
Genes: GLS; GLS1; KIAA0838
Study 32036486 — Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): TNF related activation protein
Genes: CD40LG; CD40L; TNFSF5; TRAP
Study 32037403 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 32037403 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 32039215 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 32040549 — Predictive Biomarker (PRD): GPRC5D mRNA
Genes: GPRC5D
Study 32041862 — Predictive Biomarker (PRD): TLR2 mRNA
Genes: TLR2; TIL4
Study 32041862 — Predictive Biomarker (PRD): CD28 mRNA
Genes: CD28
Study 32041862 — Predictive Biomarker (PRD): TLR2
Genes: TIL4; CD282
Study 32043771 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 32043771 — Predictive Biomarker (PRD): Hormone receptor
Study 32044400 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study 32044401 — Surrogate Endpoint (SUR): Bone mineral density
Study 32045475 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 32046348 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 32046725 — Predictive Biomarker (PRD): MBP mRNA
Genes: MBP
Study 32047009 — Predictive Biomarker (PRD): GLS mRNA
Genes: GLS; GLS1; KIAA0838
Study 32047722 — Safety Biomarker (SAF): Reactive oxygen species
Study 32047896 — Predictive Biomarker (PRD): IL1RL1 mRNA
Genes: IL1RL1; DER4; ST2; T1
Study 32047896 — Safety Biomarker (SAF): Aminopeptidase N
Genes: ANPEP; APN; CD13; PEPN
Study 32048754 — Surrogate Endpoint (SUR): Bone mineral density
Study 32049318 — Predictive Biomarker (PRD): CD80 mRNA
Genes: CD80; CD28LG; CD28LG1; LAB7
Study 32049318 — Pharmacodynamic Biomarker (PDY): T-lymphocyte activation antigen CD86
Genes: CD86; CD28LG2
Study 32050956 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 32052016 — Predictive Biomarker (PRD): IDE mRNA
Genes: IDE
Study 32052016 — Safety Biomarker (SAF): Biliary glycoprotein 1
Genes: CEACAM1; BGP; BGP1
Study 32052473 — Predictive Biomarker (PRD): TNFRSF9 mRNA
Genes: TNFRSF9; CD137; ILA
Study 32052523 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32053113 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32053113 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 32053203 — Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Neurofilament light polypeptide
Genes: NEFL; NF68; NFL
Study 32053203 — Predictive Biomarker (PRD): SLFN11 mRNA
Genes: SLFN11
Study 32053203 — Predictive Biomarker (PRD): APOBEC3G mRNA
Genes: APOBEC3G; MDS019
Study 32054467 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 32055239 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 32055239 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study 32055239 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study 32055239 — Predictive Biomarker (PRD): LUM mRNA
Genes: LUM; LDC; SLRR2D
Study 32055404 — Predictive Biomarker (PRD): FHL5 mRNA
Genes: FHL5; ACT
Study 32055862 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 32056017 — Predictive Biomarker (PRD): LSS mRNA
Genes: LSS; OSC
Study 32056676 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 32057467 — Predictive Biomarker (PRD): Microsatellite instability
Study 32057706 — Predictive Biomarker (PRD): DSE mRNA
Genes: DSE; SART2
Study 32058557 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 32058843 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 32060053 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 32060053 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 32060053 — Predictive Biomarker (PRD): Hormone receptor
Study 32060403 — Predictive Biomarker (PRD): CD79B mRNA
Genes: CD79B; B29; IGB
Study 32060403 — Predictive Biomarker (PRD): Apoptosis regulator Bcl-2
Genes: BCL2
Study 32060403 — Predictive Biomarker (PRD): KMT2B mRNA
Genes: KMT2B; HRX2; KIAA0304; MLL2; MLL4; TRX2; WBP7
Study 32060608 — Predictive Biomarker (PRD): TLR5 mRNA
Genes: TLR5; TIL3
Study 32060867 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 32061408 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 32061453 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 32062041 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 32063492 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 32063605 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 32063605 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 32063845 — Surrogate Endpoint (SUR): Blood pressure
Study 32065043 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 32065043 — Surrogate Endpoint (SUR): Blood pressure
Study 32065359 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 32066561 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 32067158 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study 32067679 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study 32067679 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study 32067679 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 32067679 — Predictive Biomarker (PRD): MAP3K1 mRNA
Genes: MAP3K1; MAPKKK1; MEKK; MEKK1
Study 32067679 — Predictive Biomarker (PRD): Hormone receptor
Study 32067683 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 32067683 — Predictive Biomarker (PRD): Protein patched homolog 1
Genes: PTCH1; PTCH
Study 32067683 — Predictive Biomarker (PRD): SMO mRNA
Genes: SMO; SMOH
Study 32067683 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Tumor mutational burden
Study 32068113 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study 32072161 — Predictive Biomarker (PRD); Safety Biomarker (SAF): miR-122
Genes: MIR122
Study 32072570 — Safety Biomarker (SAF): miR-200a
Genes: MIR200A
Study 32073546 — Predictive Biomarker (PRD): NPC1 mRNA
Genes: NPC1
Study 32073681 — Pharmacodynamic Biomarker (PDY): Leucine-rich repeat kinase 2
Genes: LRRK2; PARK8
Study 32073681 — Pharmacodynamic Biomarker (PDY): Lysosomal acid glucosylceramidase
Genes: GBA1; GBA; GC; GLUC
Study 32073681 — Safety Biomarker (SAF): SLC6A3
Genes: DAT
Study 32074275 — Predictive Biomarker (PRD): IDH2 mRNA
Genes: IDH2
Study 32074275 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 32074665 — Surrogate Endpoint (SUR): Serum calcium
Study 32075827 — Surrogate Endpoint (SUR): Blood pressure
Study 32076579 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study 32076889 — Surrogate Endpoint (SUR): Serum uric acid
Study 32077361 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 32078016 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 32078124 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study 32078381 — Surrogate Endpoint (SUR): Blood pressure
Study 32078813 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 32078813 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study 32079624 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 32079690 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 32079690 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 32079690 — Predictive Biomarker (PRD): Hepatitis A virus cellular receptor 2
Genes: HAVCR2; TIM3; TIMD3
Study 32079690 — Predictive Biomarker (PRD): LAG3 mRNA
Genes: LAG3; FDC
Study 32079690 — Predictive Biomarker (PRD): Forkhead box protein P3
Genes: FOXP3; IPEX; JM2
Study 32079690 — Predictive Biomarker (PRD): TBX21 mRNA
Genes: TBX21; TBET; TBLYM
Study 32079702 — Predictive Biomarker (PRD): NFKBIE mRNA
Genes: NFKBIE; IKBE
Study 32079702 — Predictive Biomarker (PRD): TNFAIP3 mRNA
Genes: TNFAIP3; OTUD7C
Study 32079702 — Predictive Biomarker (PRD): PTPN1 mRNA
Genes: PTPN1; PTP1B
Study 32079702 — Safety Biomarker (SAF): Beta-2-microglobulin
Genes: B2M; CDABP0092; HDCMA22P
Study 32079702 — Predictive Biomarker (PRD): ITPKB mRNA
Genes: ITPKB
Study 32079702 — Predictive Biomarker (PRD): GNA13 mRNA
Genes: GNA13
Study 32079702 — Predictive Biomarker (PRD): SOCS1 mRNA
Genes: SOCS1; SSI1; TIP3
Study 32079702 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 32080135 — Surrogate Endpoint (SUR): Blood pressure
Study 32080210 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 32080210 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 32083013 — Predictive Biomarker (PRD): CDCA7L mRNA
Genes: CDCA7L; HR1; JPO2; R1
Study 32083996 — Surrogate Endpoint (SUR): Hematologic response
Study 32085707 — Surrogate Endpoint (SUR): Blood pressure
Study 32086343 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study 32086343 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Tumor mutational burden
Study 32086361 — Predictive Biomarker (PRD): DBI mRNA
Genes: DBI
Study 32087304 — Predictive Biomarker (PRD): ATG13 mRNA
Genes: ATG13; KIAA0652
Study 32087304 — Predictive Biomarker (PRD): ATG5 mRNA
Genes: ATG5; APG5L; ASP
Study 32088322 — Predictive Biomarker (PRD): IFNL3 mRNA
Genes: IFNL3; IL28B; IL28C; ZCYTO22
Study 32088663 — Predictive Biomarker (PRD): C5AR2 mRNA
Genes: C5AR2; C5L2; GPR77
Study 32088879 — Surrogate Endpoint (SUR): Blood pressure
Study 32089164 — Predictive Biomarker (PRD): CCR5 mRNA
Genes: CCR5; CMKBR5
Study 32089871 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 32090339 — Safety Biomarker (SAF): ABCC3
Genes: MRP3; cMOAT2; EST90757; MLP2; MOAT-D
Study 32090723 — Predictive Biomarker (PRD): DPEP1 mRNA
Genes: DPEP1; MDP; RDP
Study 32091590 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 32092139 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study 32092139 — Predictive Biomarker (PRD): RUNX1 mRNA
Genes: RUNX1; AML1; CBFA2
Study 32092139 — Predictive Biomarker (PRD): RUNX1T1 mRNA
Genes: RUNX1T1; AML1T1; CBFA2T1; CDR; ETO; MTG8; ZMYND2
Study 32092139 — Predictive Biomarker (PRD); Safety Biomarker (SAF): MYH11 mRNA
Genes: MYH11; KIAA0866
Study 32092928 — Predictive Biomarker (PRD): C1QL1 mRNA
Genes: C1QL1; C1QRF; CRF; CTRP14
Study 32095087 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32095777 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study 32095777 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 32096433 — Predictive Biomarker (PRD): RALA mRNA
Genes: RALA; RAL
Study 32097091 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 32098623 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 32098855 — Pharmacodynamic Biomarker (PDY): Major prion protein
Genes: PRNP; ALTPRP; PRIP; PRP
Study 32100175 — Predictive Biomarker (PRD): BAG3 mRNA
Genes: BAG3; BIS
Study 32101140 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 32101140 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study 32101275 — Predictive Biomarker (PRD): OCA2 mRNA
Genes: OCA2; D15S12; P
Study 32101614 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 32103268 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 32103268 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32103499 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study 32103499 — Predictive Biomarker (PRD): CEBPA mRNA
Genes: CEBPA; CEBP
Study 32103499 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study 32103499 — Predictive Biomarker (PRD): CSF3R mRNA
Genes: CSF3R; GCSFR
Study 32103756 — Predictive Biomarker (PRD): SHBG mRNA
Genes: SHBG
Study 32103756 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 32105212 — Surrogate Endpoint (SUR): Blood pressure
Study 32105622 — Pharmacodynamic Biomarker (PDY): Tropomyosin-related kinase A
Genes: NTRK1; MTC; TRK; TRKA
Study 32106302 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 32106874 — Predictive Biomarker (PRD): FES mRNA
Genes: FES; FPS
Study 32107021 — Surrogate Endpoint (SUR): Blood pressure
Study 32107341 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 32107712 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 32107887 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 32108228 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study 32109631 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 32109839 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 32109839 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 32110025 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 32111358 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 32111923 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 32112982 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 32112982 — Predictive Biomarker (PRD): EML4 mRNA
Genes: EML4; C2orf2; EMAPL4
Study 32114500 — Predictive Biomarker (PRD): CD70 mRNA
Genes: CD70; CD27L; CD27LG; TNFSF7
Study 32114500 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study 32114500 — Predictive Biomarker (PRD): TLR4 mRNA
Genes: TLR4
Study 32115672 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 32115672 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 32115672 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32115672 — Safety Biomarker (SAF): BDNF
Study 32119939 — Predictive Biomarker (PRD): EVL mRNA
Genes: EVL; RNB6
Study 32121153 — Surrogate Endpoint (SUR): Serum creatinine
Study 32122334 — Predictive Biomarker (PRD): CAPS mRNA
Genes: CAPS
Study 32122345 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study 32122366 — Predictive Biomarker (PRD): ADAMTS13 mRNA
Genes: ADAMTS13; C9orf8; UNQ6102/PRO20085
Study 32122366 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study 32122366 — Safety Biomarker (SAF): Antithrombin-III
Genes: SERPINC1; AT3; PRO0309
Study 32122899 — Surrogate Endpoint (SUR): Serum creatinine
Study 32122924 — Predictive Biomarker (PRD): EZH2 mRNA
Genes: EZH2; KMT6
Study 32125711 — Surrogate Endpoint (SUR): Bone mineral density
Study 32125937 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 32126141 — Predictive Biomarker (PRD): RB1
Genes: RB; PPP1R130
Study 32127922 — Predictive Biomarker (PRD): SPN mRNA
Genes: SPN; CD43
Study 32128723 — Surrogate Endpoint (SUR): Blood pressure
Study 32131847 — Predictive Biomarker (PRD): LIPA mRNA
Genes: LIPA
Study 32134216 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32134216 — Monitoring Biomarker (MOI): Procalcitonin
Study 32134933 — Surrogate Endpoint (SUR): Blood pressure
Study 32134978 — Predictive Biomarker (PRD); Safety Biomarker (SAF): SRD5A2 mRNA
Genes: SRD5A2
Study 32135566 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study 32138781 — Predictive Biomarker (PRD): ACD mRNA
Genes: ACD; PIP1; PTOP; TINT1; TPP1
Study 32138781 — Predictive Biomarker (PRD): COTL1 mRNA
Genes: COTL1; CLP
Study 32139220 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study 32139298 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 32139298 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 32140080 — Predictive Biomarker (PRD): FHL5 mRNA
Genes: FHL5; ACT
Study 32140727 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32140727 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 32140912 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study 32142532 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study 32143585 — Predictive Biomarker (PRD): FST mRNA
Genes: FST
Study 32143664 — Predictive Biomarker (PRD): HPR mRNA
Genes: HPR
Study 32144134 — Predictive Biomarker (PRD): TNFRSF9 mRNA
Genes: TNFRSF9; CD137; ILA
Study 32144134 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 32145771 — Predictive Biomarker (PRD): IDH2 mRNA
Genes: IDH2
Study 32146304 — Predictive Biomarker (PRD): PRCC mRNA
Genes: PRCC; TPRC
Study 32146304 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 32147213 — Safety Biomarker (SAF): Interleukin 12
Study 32147213 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 32147669 — Predictive Biomarker (PRD): MAP2K1 mRNA
Genes: MAP2K1; MEK1; PRKMK1
Study 32147669 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 32147669 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 32147671 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study 32149736 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study 32149736 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Plasma DNA
Study 32152160 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study 32152168 — Predictive Biomarker (PRD): LARS1 mRNA
Genes: LARS1; KIAA1352; LARS
Study 32152172 — Surrogate Endpoint (SUR): Blood pressure
Study 32152173 — Safety Biomarker (SAF): Human leucocyte antigen
Study 32152221 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 32152221 — Predictive Biomarker (PRD): CD28 mRNA
Genes: CD28
Study 32152221 — Predictive Biomarker (PRD): CXCR3 mRNA
Genes: CXCR3; GPR9
Study 32152221 — Predictive Biomarker (PRD): ARHGEF5 mRNA
Genes: ARHGEF5; TIM
Study 32152221 — Predictive Biomarker (PRD): CCR5 mRNA
Genes: CCR5; CMKBR5
Study 32152628 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study 32153780 — Predictive Biomarker (PRD): TLR7 mRNA
Genes: TLR7; UNQ248/PRO285
Study 32153780 — Predictive Biomarker (PRD): WT1 mRNA
Genes: WT1
Study 32153780 — Predictive Biomarker (PRD): PRAME mRNA
Genes: PRAME; MAPE; OIP4
Study 32153825 — Surrogate Endpoint (SUR): Blood pressure
Study 32153916 — Predictive Biomarker (PRD): ANGPTL3 mRNA
Genes: ANGPTL3; ANGPT5; UNQ153/PRO179
Study 32153916 — Predictive Biomarker (PRD): Angiopoietin-related protein 4
Genes: ANGPTL4; ARP4; HFARP; PGAR; PP1158; PSEC0166; UNQ171/PRO197
Study 32153916 — Predictive Biomarker (PRD): ANGPTL8 mRNA
Genes: ANGPTL8; C19orf80; RIFL; UNQ599/PRO1185
Study 32153916 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 32154325 — Predictive Biomarker (PRD): REL mRNA
Genes: REL
Study 32154497 — Predictive Biomarker (PRD): SI mRNA
Genes: SI
Study 32154962 — Predictive Biomarker (PRD): DNAJB1 mRNA
Genes: DNAJB1; DNAJ1; HDJ1; HSPF1
Study 32154962 — Predictive Biomarker (PRD): PRKACA mRNA
Genes: PRKACA; PKACA
Study 32154962 — Predictive Biomarker (PRD): Aurora kinase A
Genes: AURKA; AIK; AIRK1; ARK1; AURA; AYK1; BTAK; IAK1; STK15; STK6
Study 32155200 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 32156491 — Predictive Biomarker (PRD): Vitamin D-binding protein
Genes: GC
Study 32156630 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 32156743 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study 32156743 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study 32156743 — Predictive Biomarker (PRD): SYK mRNA
Genes: SYK
Study 32158204 — Surrogate Endpoint (SUR): Blood pressure
Study 32158204 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 32158204 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32160304 — Predictive Biomarker (PRD): KISS1 mRNA
Genes: KISS1; PP5098
Study 32160304 — Predictive Biomarker (PRD): PLCB1 mRNA
Genes: PLCB1; KIAA0581
Study 32160304 — Predictive Biomarker (PRD): PRKCA mRNA
Genes: PRKCA; PKCA; PRKACA
Study 32160304 — Predictive Biomarker (PRD): ITPR1 mRNA
Genes: ITPR1; INSP3R1